Literature DB >> 24067602

Fertility sparing treatment of recurrent stage I serous borderline ovarian tumours.

Catherine Uzan1, Eve Muller, Aminata Kane, Sebastien Gouy, Sofiane Bendifallah, Raffaelle Fauvet, Emile Darai, Philippe Morice.   

Abstract

Here we report the outcomes of 26 patients who relapsed following conservative surgical treatment of stage I serous borderline ovarian tumours treated initially with fertility-sparing surgery. All recurrences were diagnosed by systematic ultrasonography during follow-up. Eleven patients relapsed at least twice after such management. Twenty-one pregnancies were observed in 13 patients. Eleven of these patients became pregnant after the treatment of their first recurrence. All patients had a borderline ovarian tumour and/or non-invasive peritoneal implants at the time of the first recurrence but two of them had invasive ovarian and peritoneal disease at the time of the second or third recurrence (one of them died of disease). Fertility-preserving surgery remains a valuable alternative (if technically feasible), in young patients with recurrent SBOT, in the form of a non-invasive ovarian lesion, who wish to start a pregnancy. However, it should be associated with meticulous follow-up because the risk of progression to carcinoma exists, albeit small.

Entities:  

Keywords:  borderline tumour; conservative treatment; ovary; recurrence; serous tumour

Mesh:

Year:  2013        PMID: 24067602     DOI: 10.1093/humrep/det371

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  8 in total

Review 1.  Role of ultrasound in the detection of recurrent ovarian cancer: a review of the literature.

Authors:  Andrea Rosati; Salvatore Gueli Alletti; Vito Andrea Capozzi; Mariateresa Mirandola; Virginia Vargiu; Camilla Fedele; Stefano Uccella; Carmine Vascone
Journal:  Gland Surg       Date:  2020-08

Review 2.  Fertility sparing treatment in borderline ovarian tumours.

Authors:  Rosa Maria Alvarez; Daniel Vazquez-Vicente
Journal:  Ecancermedicalscience       Date:  2015-02-03

3.  Safety and fertility outcomes after the conservative treatment of endometrioid borderline ovarian tumours.

Authors:  Shuang-Zheng Jia; Jun-Ji Zhang; Zhi-Yong Liang; Jun-Jun Yang; Yang Xiang; Cong-Wei Jia; Jin-Hua Leng
Journal:  BMC Cancer       Date:  2018-11-23       Impact factor: 4.430

4.  Outcomes of fertility-sparing surgery for stage II and III serous borderline ovarian tumors.

Authors:  Ziyang Lu; Bin Li; Chao Gu
Journal:  J Int Med Res       Date:  2019-08-21       Impact factor: 1.671

5.  Identification of clinical and molecular features of recurrent serous borderline ovarian tumour.

Authors:  Ziyang Lu; Fanghe Lin; Tao Li; Jinhui Wang; Cenxi Liu; Guangxing Lu; Bin Li; MingPei Pan; Shaohua Fan; Junqiu Yue; He Huang; Jia Song; Chao Gu; Jin Li
Journal:  EClinicalMedicine       Date:  2022-04-08

6.  Risk Factors for Recurrence of Borderline Ovarian Tumours after Conservative Surgery and Impact on Fertility: A Multicentre Study by the Francogyn Group.

Authors:  Adele Ozenne; Marion De Berti; Gilles Body; Xavier Carcopino; Olivier Graesslin; Yohan Kerbage; Cherif Akladios; Cyrille Huchon; Alexandre Bricou; Camille Mimoun; Emilie Raimond; Lobna Ouldamer
Journal:  J Clin Med       Date:  2022-06-23       Impact factor: 4.964

7.  Second fertility-sparing surgery and fertility-outcomes in patients with recurrent borderline ovarian tumors.

Authors:  Lifei Wang; Qian Zhong; Qin Tang; Hongjing Wang
Journal:  Arch Gynecol Obstet       Date:  2022-03-23       Impact factor: 2.493

Review 8.  Borderline ovarian tumours: management in the era of fertility-sparing surgery.

Authors:  Mattia Maramai; Fabio Barra; Mario Valenzano Menada; Sara Stigliani; Melita Moioli; Sergio Costantini; Simone Ferrero
Journal:  Ecancermedicalscience       Date:  2020-05-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.